Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unituxin and IL-2 in High-Risk Neuroblastoma
NCT02641782Phase 2Terminated
- Sponsor
- University of Cologne
- Start
- Nov 2015
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in neuroblastoma, sponsored by University of Cologne. Started Nov 2015; status: terminated.
02
Drugs
aldesleukin
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT02641782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02641782.